Zafgen (ZFGN) Tops Q1 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq retreat from record highs as yields and oil climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
Canaccord Genuity Maintain Buy Following Zafgen (ZFGN) Q1 Results
May 13, 2015 10:44 AM EDTCanaccord Genuity maintain a Buy rating on Zafgen (NASDAQ: ZFGN), and lowered the price target to $53.00 (from $58.00), following Q1 results. Zafgen reported Q1 EPS of ($0.53), beating Canaccord's estimate of ($0.62) by $0.09. During the last earnings call, it was announced that data from the Ph3 Prader-Willi Syndrom (PWS) trial would be delayed until 2Q16.... More



